162 related articles for article (PubMed ID: 3444845)
1. [Resistance and disintegration behavior of gastric juice-resistant drug products. 3. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
Thoma K; Heckenmüller H; Oschmann R
Pharmazie; 1987 Dec; 42(12):832-6. PubMed ID: 3444845
[TBL] [Abstract][Full Text] [Related]
2. [Effect of film formers and plasticizers on the stability of resistance and disintegration behavior. 4. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
Thoma K; Heckenmüller H
Pharmazie; 1987 Dec; 42(12):837-41. PubMed ID: 3444846
[TBL] [Abstract][Full Text] [Related]
3. [The solubility kinetics of enteric-resistant tablets using riboflavin test tablets. 6. Pharmaceutic-technologic and analytic studies on gastric juice-resistant dosage forms].
Thoma K; Oschmann R
Pharmazie; 1991 May; 46(5):331-6. PubMed ID: 1896478
[TBL] [Abstract][Full Text] [Related]
4. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
Kibria G; Islam KM; Jalil RU
Pak J Pharm Sci; 2009 Jan; 22(1):36-43. PubMed ID: 19168418
[TBL] [Abstract][Full Text] [Related]
5. [The pH-endoradio transmitter: a method for studying the decomposition of gastric juice resistant enteric-coated pharmaceutical preparations in the intestine. 2. Decomposition time of gastric juice resistant enteric-coated hard gelain capsules].
Eckert T; Rothgang G; Seidel R
Arzneimittelforschung; 1968 Mar; 18(3):372-3. PubMed ID: 5696018
[No Abstract] [Full Text] [Related]
6. Enteric-coated solid dosage forms containing sodium bicarbonate as a drug substance: an exception from the rule?
Breitkreutz J; Gan TG; Schneider B; Kalisch P
J Pharm Pharmacol; 2007 Jan; 59(1):59-65. PubMed ID: 17227621
[TBL] [Abstract][Full Text] [Related]
7. Development of sensor elements to control drug release from capsular drug delivery systems.
Gröning R; Danco I; Müller RS
Int J Pharm; 2007 Aug; 340(1-2):61-4. PubMed ID: 17462841
[TBL] [Abstract][Full Text] [Related]
8. Studies comparing Kollicoat MAE 30 D with commercial cellulose derivatives for enteric coating on caffeine cores.
Scheiffele S; Kolter K; Schepky G
Drug Dev Ind Pharm; 1998 Sep; 24(9):807-18. PubMed ID: 9876531
[TBL] [Abstract][Full Text] [Related]
9. [Thin layer chromatographic detection of emollients in gastric juice-resistant coatings. 2. The pharmaceutic technology and analysis of gastric juice-resistant dosage forms].
Thoma K; Heckenmüller H
Pharmazie; 1986 May; 41(5):328-32. PubMed ID: 3737663
[TBL] [Abstract][Full Text] [Related]
10. [Lacquered tablets and film dragees].
Hess H; Janssen HJ
Pharm Acta Helv; 1969 Oct; 44(10):581-601. PubMed ID: 4901296
[No Abstract] [Full Text] [Related]
11. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
12. The manufacture and characterisation of hot-melt extruded enteric tablets.
Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
[TBL] [Abstract][Full Text] [Related]
13. Stability of dry coated solid dosage forms.
Kablitz CD; Urbanetz NA
Pharm Dev Technol; 2009; 14(6):613-22. PubMed ID: 19883250
[TBL] [Abstract][Full Text] [Related]
14. [Resistance of cardiac glycoside preparations to leander, gastric juice, hydrochloric acid, high temperature and in prolonged storage].
Sila VI
Aptechn Delo; 1965; 14(6):72-4. PubMed ID: 5896168
[No Abstract] [Full Text] [Related]
15. An investigation of the disintegration of tablets in biorelevant media.
Anwar S; Fell JT; Dickinson PA
Int J Pharm; 2005 Feb; 290(1-2):121-7. PubMed ID: 15664137
[TBL] [Abstract][Full Text] [Related]
16. Hollow microspheres of diclofenac sodium - a gastroretentive controlled delivery system.
Bv B; R D; S B; Abraham S; Furtado S; V M
Pak J Pharm Sci; 2008 Oct; 21(4):451-4. PubMed ID: 18930869
[TBL] [Abstract][Full Text] [Related]
17. Disintegration of sublingual tablets: proposal for a validated test method and acceptance criterion.
Weda M; van Riet-Nales DA; van Aalst P; de Kaste D; Lekkerkerker JF
Pharmeur Sci Notes; 2006 Dec; 2006(2):41-4. PubMed ID: 17691213
[TBL] [Abstract][Full Text] [Related]
18. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
[TBL] [Abstract][Full Text] [Related]
19. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
20. The stability of human pepsins in stored gastric juice.
Whitecross DP; Piper DW
Scand J Gastroenterol; 1975; 10(4):395-9. PubMed ID: 239449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
